Posts by Brian Westerlind
What is the HPUS and Who Creates It?
By Eric L. Foxman, R.Ph., senior scientist, HPCUS Homeopathic pharmacopoeias have been published continually since the 1840s. The Homeopathic Pharmacopoeia of the United States (HPUS) has been in continuous publication…
Read MoreFDA Warning Letter Lessons?
By Eric L. Foxman, R.PH., AAHP Secretary Of all the Warning Letters issued by the FDA, very few go to homeopathic manufacturers or marketers. That’s good. On the other hand,…
Read More2020 Presidential & Congressional Elections: Outcome and Agenda Outlook in the 117th Congress
By Pete Evich, AAHP Regulatory Affairs Presidency and Congress President-elect Joe Biden managed to defeat an incumbent president — the first time that’s happened in 28 years. Sen. Kamala…
Read More2020: A Year of Resiliency and Determination
By Mark Land, AAHP President As remarkable as the limitations of this pandemic year have been, I am also astonished by the resiliency of people, technology, and organizations including AAHP.…
Read MoreHow Real-World Data Is Impacting Health Care Decisions Today
By Mark Land, AAHP President I have been interested in the application of Real-World Data (RWD) and Real-World Evidence (RWE) for some time now. Originally, I confused RWD and RWE…
Read MoreHomeopathic Process Validation for Beginners
Consistent, effective, high-quality homeopathic products. That’s what our consumers want in each and every dose. Yet quality doesn’t happen by accident. Manufacturers must create it through process validation. Each manufacturer…
Read MoreNew Regulatory Requirement; Know What to You Need to Comply
“Since the beginning of September 2020, CGMP regulations now require all manufacturers of drug products to detect and quantify any methanol present in each lot of alcohol they receive. Assurance…
Read MoreNew FDA Report on the State of Pharmaceutical Quality
By Mark Land, AAHP President A quality drug is consistently safe, effective, and free of contamination or defects. Patients and consumers expect quality drugs with every dose they take. The…
Read MoreNotes on the Future: AAHP Outlook 2020
AAHP’s Board of Directors just completed its fourth annual strategy retreat. Together we reflected on the accomplishments, challenges, and opportunities we’ve had during this truly unprecedented year. Throughout the COVID-19…
Read MoreAAHP Reinforces MediNatura’s Defense Against FDA Action
In support of our member company MediNatura, Inc. challenging FDA’s attack on its prescription injectable homeopathic products, AAHP filed an amicus brief in the United States District Court for the…
Read More